Medical Innovations

Daraxonrasib at ASCO 2026: Are we entering a new era in pancreatic cancer treatment?

For decades, pancreatic cancer has been considered one of the greatest challenges in modern oncology. Characterized by late-stage diagnosis, aggressive […]